Infinita Expert

Stephen Martin. Expert Consultation.

Patient Access & Right-to-Try Strategy for Experimental Treatments.
Work directly with Stephen Martin to evaluate patient access opportunities through emerging state-level clinical pathways.

Together, you'll develop a submission strategy, and prepare your treatment for independent review under applicable frameworks.
Book 30-MinuteBook 30-Minute
Designed for biotechs preparing experimental treatment submissions.
DISCLAIMER: Independent scientific guidance. Consultations do not influence the outcome of any independent review process.
Preparing for Your Consultation.
To make the most of your session, share any available background information in advance, including a brief description of the therapy, supporting evidence, development stage, and any specific scientific questions they would like to discuss.
Submit Information
Selected Credentials
200+
Scientific Publications.
20+
Years of Research.
3
Scientific Fellowships.
01 OVERVIEW

Why Book This Consultation.

Experimental treatment submissions require scientific decisions that often extend beyond published guidance.

Evaluating evidence quality, identifying potential risks, and strengthening submission strategy all benefit from expert review before important decisions are made.
This consultation gives treatment developers direct access to Matt Kaeberlein's scientific insight to evaluate their therapy, strengthen submission strategy, and move forward with greater confidence.

How the Consultation Works.

Hear directly from Matt Kaeberlein about the scientific approach behind this consultation and how it can strengthen your treatment development strategy.
‍
·

Strengthen Your Submission.

Receive expert feedback to improve the scientific foundation of your therapy before independent review.
·

Reduce Scientific Risk.

Identify potential weaknesses, evidence gaps, and strategic questions before they become costly delays.
·

Accelerate Decision Making.

Receive expert feedback to improve the scientific foundation of your therapy before independent review.
Designed for biotechs preparing
experimental treatment submissions.
Book Consultation
02 Details

Consultation Scope.

Every consultation with Matt Kaeberlein is tailored to the current stage, challenges, and objectives of your treatment.
The discussion may include one or more of the focus areas below, depending on your treatment's priorities.

Scientific Rationale.

Evaluate whether the scientific foundation of your therapy is ready for submission.

Evidence Review.

Assess supporting data, identify evidence gaps, and discuss opportunities to strengthen your submission..

Submission Strategy.

Receive expert feedback to improve the scientific foundation of your therapy before independent review.

Development Planning.

Review next steps based on your therapy's current stage and long-term objectives.

Clinical Translation.

Explore practical considerations for moving promising therapies toward patient access.

Open Scientific Discussion

Bring specific questions about your therapy, development program, or submission strategy.

Consultation Details:

Duration:
30 or 60 min
Format:
Remote (Google Meet)
Availability:
Mon-Fri, 09:00-12:00
Time Zone:
Pacific Time (UTC−8)

Best Suited For:

▪ Biotechnology companies

▪ Clinical-stage therapeutic developers

▪ Research organizations

▪ Sponsors preparing experimental treatment submissions

▪ Teams evaluating scientific evidence and development strategy

Expected Outcomes:

▪ Clear next steps for your treatment strategy

▪ Practical scientific recommendations

▪ Greater confidence in your submission approach

▪ Answers to your most important technical questions
EXPERT PROFILE

Operational Leadership.

Stephen Martin leads U.S. initiatives at Infinita focused on expanding responsible patient access to experimental treatments through emerging state-level frameworks.

His work centers on translating legislation into practical clinical pathways by working closely with biotechnology companies, policymakers, clinicians, and independent review organizations.

Stephen has played a central role in the development and implementation of Montana's Experimental Treatment Review Board and has worked directly with treatment developers preparing therapies for clinical access under SB 535.
His experience spans pathway implementation, submission strategy, operational compliance, and patient access policy, helping biotechnology teams navigate new opportunities beyond conventional development models.

Professional Highlights.

U.S. Lead:
Infinita
Operations Lead:
Montana Experimental Treatment Review Board (METRB)
Speaker:
Right-to-Try & Patient Access Policy
Co-Founder:
GenePool Technologies

Affiliations.

GenePool

Montana ETRB

The Alliance for Longevity Initiatives

Learn More.

Explore Stephen Martin's background.

Montana ETRB ↗

GenePool ↗

LinkedIn ↗

X (Twitter) ↗ .
Book Consultation
Expert guidance for critical scientific
and submission decisions.
03 Process

Consultation Process.

Every consultation follows a straightforward process designed to maximize the value of your time with Matt Kaeberlein.
From booking to preparation and the consultation itself and follow ups, each step is focused on providing practical scientific guidance tailored to your therapy.

01—

Schedule Your Consultation.

Select the consultation length that best fits your needs and choose an available time directly from Matt Kaeberlein's calendar.

02—

Share Your Background.

Before the meeting, provide any relevant materials, including information about your therapy, supporting evidence, development stage, and the scientific questions you'd like to discuss.

This allows the consultation to focus immediately on the topics most relevant to your team.

03—

Iterate with
Matt Kaeberlein.

Discuss your therapy directly with Matt, receive scientific feedback tailored to your treatment, explore strategic questions, and leave with practical recommendations for your next stage of development.
03 Process

Consultation Process.

Every consultation follows a straightforward process designed to maximize the value of your time with Matt Kaeberlein.
From booking to preparation and the consultation itself and follow ups, each step is focused on providing practical scientific guidance tailored to your therapy.

01—

Schedule Your Consultation.

Select the consultation length that best fits your needs and choose an available time directly from Matt Kaeberlein's calendar.

02—

Share Your Background.

Before the meeting, provide any relevant materials, including information about your therapy, supporting evidence, development stage, and the scientific questions you'd like to discuss.

03—

Iterate with Matt Kaeberlein.

Discuss your therapy directly with Matt, receive scientific feedback tailored to your treatment, explore strategic questions, and leave with practical recommendations for your next stage of development.